As the second Trump administration ushers in changes across federal agencies, medical device companies must stay vigilant in their promotional and advertising practices. Arnold & Porter partners Phil Desjardins and Raqiyyah Pippins will provide an overview of the U.S. Food and Drug Administration and Federal Trade Commission's respective roles in regulating medical device marketing. We will clarify jurisdiction, enforcement priorities, and the types of claims that can trigger scrutiny. This program will provide a refresher on core regulatory principles governing device promotion and advertising, insight into recent enforcement actions and policy updates from both agencies, strategic guidance for managing promotional review processes and minimizing regulatory risk, and practical tips for aligning your marketing approach with evolving expectations under the current administration.
Webinar Series Alert
Part VIII: Regulatory Strategies in Europe for MedTech
Thursday, September 25
11 a.m.-noon ET
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
